People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Plasmonix, Inc. | — | Biotechnology | Seed | $2.9M | $24.1M | 2014 |
David W. Manyak at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David W. Manyak on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John W. Holaday | 1 | 3 |
| William M. Gust, II | 1 | 1 |
| Edward M. Rudnic, PhD | 1 | 1 |
| Jesse W. Baumgold, PhD | 1 | 1 |
| Sean M. Higgins, PhD | 1 | 1 |
| Jesse E. Baumgold, PhD | 1 | 1 |
| James E. Russo | 1 | 1 |
| Christopher D. Geddes | 1 | 1 |
| Steven W. Meltzer | 1 | 1 |
| Jesse Baumgold, PhD | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.